Back to Search Start Over

The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality.

Authors :
Gaither, Julie
Goulet, Joseph
Becker, William
Crystal, Stephen
Edelman, E.
Gordon, Kirsha
Kerns, Robert
Rimland, David
Skanderson, Melissa
Justice, Amy
Fiellin, David
Gaither, Julie R
Goulet, Joseph L
Becker, William C
Edelman, E Jennifer
Kerns, Robert D
Justice, Amy C
Fiellin, David A
Source :
JGIM: Journal of General Internal Medicine; May2016, Vol. 31 Issue 5, p492-501, 10p
Publication Year :
2016

Abstract

<bold>Purpose: </bold>For patients receiving long-term opioid therapy (LtOT), the impact of guideline-concordant care on important clinical outcomes--notably mortality--is largely unknown, even among patients with a high comorbidity and mortality burden (e.g., HIV-infected patients). Our objective was to determine the association between receipt of guideline-concordant LtOT and 1-year all-cause mortality.<bold>Methods: </bold>Among HIV-infected and uninfected patients initiating LtOT between 2000 and 2010 through the Department of Veterans Affairs, we used Cox regression with time-updated covariates and propensity-score matched analyses to examine the association between receipt of guideline-concordant care and 1-year all-cause mortality.<bold>Results: </bold>Of 17,044 patients initiating LtOT between 2000 and 2010, 1048 patients (6%) died during 1 year of follow-up. Patients receiving psychotherapeutic co-interventions (hazard ratio [HR] 0.62; 95% confidence interval [CI] 0.51-0.75; P < 0.001) or physical rehabilitative therapies (HR 0.81; 95% CI 0.67-0.98; P = 0.03) had a decreased risk of all-cause mortality compared to patients not receiving these services, whereas patients prescribed benzodiazepines concurrent with opioids had a higher risk of mortality (HR 1.39; 95% CI 1.12-1.66; P < 0.001). Among patients with a current substance use disorder (SUD), those receiving SUD treatment had a lower risk of mortality than untreated patients (HR 0.47; 95% CI 0.32-0.68; P = < 0.001). No association was found between all-cause mortality and primary care visits (HR 1.12; 95% CI 0.90-1.26; P = 0.32) or urine drug testing (HR 0.96; 95% CI 0.78-1.17; P = 0.67).<bold>Conclusions: </bold>Providers should use caution in initiating LtOT in conjunction with benzodiazepines and untreated SUDs. Patients receiving LtOT may benefit from multi-modal treatment that addresses chronic pain and its associated comorbidities across multiple disciplines. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08848734
Volume :
31
Issue :
5
Database :
Complementary Index
Journal :
JGIM: Journal of General Internal Medicine
Publication Type :
Academic Journal
Accession number :
114603323
Full Text :
https://doi.org/10.1007/s11606-015-3571-4